The Effectiveness of COVID-19 Vaccines in Improving the Outcomes of Hospitalized COVID-19 Patients
- PMID: 35103227
- PMCID: PMC8783154
- DOI: 10.7759/cureus.21485
The Effectiveness of COVID-19 Vaccines in Improving the Outcomes of Hospitalized COVID-19 Patients
Abstract
Background With the rapid spread of coronavirus disease 2019 (COVID-19), most countries took extreme measures to control the disease. Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic. The Ministry of Health program in Saudi Arabia aimed to cover 17.4 million adults (70% of the adult population of Saudi Arabia) by the third quarter of 2021. We investigated the impact of the COVID-19 vaccine on the clinical course and outcomes of the admitted confirmed COVID-19 patients, in comparison to non-vaccinated patients. Methodology A retrospective cross-sectional record review was conducted for all hospitalized confirmed COVID-19 patients at Dammam Medical Complex (Eastern Province, Saudi Arabia) from June to July 2021. Two groups were studied according to the vaccination status (i.e., vaccinated and non-vaccinated). Information regarding comorbidities, length of stay, high oxygen requirements, ICU admission, and mortality data were collected and analyzed using the Python programming language (version 3.7.6) with the use of SciPy library (1.4.1) and Statsmodels module (v0.11.1). Results The sample included a total of 260 admitted confirmed COVID-19 cases. The mortality was significantly lower in the vaccinated group versus the non-vaccinated group with an odds ratio (OR) of 0.378 (CI 0.154-0.928). In addition, the OR of ICU admission was 0.476 (CI 0.218-1.042) and OR of endotracheal intubation was 0.561 (CI 0.249-1.265), but these did not reach statistical significance. We also detected a statistically significant relationship between mortality - regardless of vaccination status - and age ≥ 65 years (P=0.000, OR=7.51; 95%CI 3.13 to 18.04), chronic kidney disease (P=0.010, OR=5.62; CI 1.52 to 20.79), and renal transplant (P=0.037, OR=10.17; CI 1.15 to 89.76). Of note, most of our vaccinated patients received only a single dose (85%). Conclusion There is a significant reduction in mortality cases as well as less complicated hospital courses among the vaccinated group, in spite of the fact that most of our admitted patients had only a single vaccine shot. Suboptimal response to the vaccines was observed in the elder, chronic kidney disease, and renal transplant patients, hence the poorer outcomes in comparison to other patients.
Keywords: admission; covid-19; icu; infection; intubation; vaccine.
Copyright © 2022, Alsaffar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.JAMA Netw Open. 2022 Oct 3;5(10):e2238871. doi: 10.1001/jamanetworkopen.2022.38871. JAMA Netw Open. 2022. PMID: 36301541 Free PMC article.
-
The Effect of COVID-19 Vaccines on Hospital Admission and Severity of Symptoms Among COVID-19 Patients in Saudi Arabia, 2021.Cureus. 2023 Jun 28;15(6):e41067. doi: 10.7759/cureus.41067. eCollection 2023 Jun. Cureus. 2023. PMID: 37519611 Free PMC article.
-
Effectiveness of COVID-19 vaccines against ICU admission during Omicron surge in Saudi Arabia: a nationwide retrospective cohort study.BMC Infect Dis. 2023 Oct 31;23(1):746. doi: 10.1186/s12879-023-08686-y. BMC Infect Dis. 2023. PMID: 37907859 Free PMC article.
-
Comorbidities associated with risk of ICU admission in elderly patients with COVID-19: Data from academic hospital in Saudi Arabia.Medicine (Baltimore). 2022 Sep 30;101(39):e30799. doi: 10.1097/MD.0000000000030799. Medicine (Baltimore). 2022. PMID: 36181092 Free PMC article.
-
The Burden of Coronavirus Disease 2019-Related Cases, Hospitalizations, and Mortality Based on Vaccination Status and Mandated Mask Use: Statewide Data From Wisconsin and Narrative Review of the Literature.Anesth Analg. 2022 Mar 1;134(3):524-531. doi: 10.1213/ANE.0000000000005858. Anesth Analg. 2022. PMID: 35180169 Review.
Cited by
-
Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A Single Center Study.Infect Drug Resist. 2023 Mar 4;16:1263-1278. doi: 10.2147/IDR.S394602. eCollection 2023. Infect Drug Resist. 2023. PMID: 36910517 Free PMC article.
-
Management of hip fracture in COVID-19 infected patients.World J Orthop. 2022 Jun 18;13(6):544-554. doi: 10.5312/wjo.v13.i6.544. eCollection 2022 Jun 18. World J Orthop. 2022. PMID: 35949705 Free PMC article. Review.
-
Vaccination Status and Number of Vaccine Doses Are Independently Associated with the PaO2/FiO2 Ratio on Admission in Hospitalized COVID-19 Patients.Vaccines (Basel). 2022 Aug 29;10(9):1424. doi: 10.3390/vaccines10091424. Vaccines (Basel). 2022. PMID: 36146502 Free PMC article.
-
Paxlovid for Treating COVID-19 Patients: A Case-Control Study From Two Hospitals in the Eastern Province of Saudi Arabia.Cureus. 2023 May 19;15(5):e39234. doi: 10.7759/cureus.39234. eCollection 2023 May. Cureus. 2023. PMID: 37337482 Free PMC article.
-
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center.Cureus. 2023 Jul 12;15(7):e41769. doi: 10.7759/cureus.41769. eCollection 2023 Jul. Cureus. 2023. PMID: 37449288 Free PMC article.
References
-
- Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Mulligan MJ, Lyke KE, Kitchin N, et al. Nature. 2020;586:589–593. - PubMed
-
- Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States [PREPRINT] Tenforde MW, Patel MM, Ginde AA, et al. medRxiv. 2021 - PubMed
LinkOut - more resources
Full Text Sources